Elsevier, Journal of Cystic Fibrosis, 4(11), p. 332-336, 2012
DOI: 10.1016/j.jcf.2012.01.001
Full text: Download
Newborn screening (NBS) for Cystic Fibrosis (CF) has been introduced in many countries, but there is no ideal protocol suitable for all countries. This retrospective study was conducted to evaluate whether the planned two step CF NBS with immunoreactive trypsinogen (IRT) and 7 CFTR mutations would have detected all clinically diagnosed children with CF in Switzerland.